top of page
  • Facebook
  • Twitter
  • Instagram
Epperson Headshot.jpeg

C. Neill Epperson, MD
Robert Freedman Endowed Professor and Chair University of Colorado Anschutz

Women's Health and Cycle-Linked Mood Disorders
Wednesday, February 10, 2027
9:00 AM - 10:00 AM

Dr. Epperson, internationally known for her unique lifespan approach to psychoneuroendocrinology and women’s brain health, has critically informed our understanding of the individual and interactive roles of gonadal hormones and childhood adversity on risk for neuropsychiatric and cognitive issues. She is one of few psychiatrists to work translationally to build clinical and basic research models to more effectively address mechanisms for suboptimal brain and mental health, as well as intergenerational transmission of risk. 

​

Dr. Epperson utilizes multiple research tools and paradigms to interrogate the issues that she has observed in her clinical practice as a reproductive psychiatrist and has been consistently NIH funded for 30 years. Dr. Epperson moves seamlessly between psychotropic and hormonal trials, multi-modal neuroimaging, stress provocation, psychophysiology, in utero ultrasound, and bench research to uniquely demonstrate the impact of sex, reproductive, and hormonal status as well as lived experience of participants on outcomes of interest. Most recently, she discovered that maternal childhood adversity impacts fetal adrenal development and infant stress responsiveness in males, but not females. She and her basic science research partner have developed models in both mice and men indicating that resolution of perceived stress impacts sperm motility, extracellular vesicle composition, and small noncoding RNA in a manner that is likely to impact offspring development. Bridging both ends of the lifespan, Dr. Epperson discovered that childhood adversity increases risk for first-onset depression during the perimenopause and alters dorsolateral prefrontal cortex function during working memory task performance in an estradiol dependent manner.
 

Lecture Summary:

This presentation will examine the relationship between hormonal fluctuations and psychiatric symptoms in females across the reproductive lifespan. The session will review how ovarian hormones influence brain function and contribute to conditions such as premenstrual dysphoric disorder, as well as the premenstrual worsening of other psychiatric disorders. It will also address strategies for accurate diagnosis and evidence-based treatment, helping clinicians recognize hormonally influenced symptom patterns and tailor interventions accordingly.

​Goals and Learning Objectives:

  • Name at least three effects of ovarian hormones on brain neurochemistry, structure, or function.

  • Accurately diagnose premenstrual dysphoric disorder.

  • Describe the treatment of premenstrual dysphoric disorder and premenstrual worsening of other psychiatric conditions.

 

Disclosures:

Consultant : Supernus, EmbarkNeuro (past), Bayer (past), J&J Global Neuroscience, MycoMedica,
Speakers' Bureau or Honoraria : Boehringer Ingelheim (past)
Ownership Interest (privately held) : BabyScripts
Other Financial Benefit : Magnus (DSMB), University of Texas Austin (DSMB)

bottom of page